Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2005 034 423.3 |
96 | EP file number | EAKZ | 05 73 8885.2 |
86 | WO file number | WAKZ | PCT/CA2005/000625 |
97 | EP publication number | EPN | 1744764 |
87 | WO publication number | WPN | 2005102359 |
54 | Designation/title | TI | LIPOSOMALE FORMULIERUNGEN VON ANTHRYCYCLIN-MITTELN UND CYTIDIN-ANALOGA |
51 | IPC main class | ICM (ICMV) | A61K 31/7068 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/704 (2006.01), A61K 31/706 (2006.01), A61K 9/127 (2025.01) |
22 | DE application date | DAT | Apr 22, 2005 |
96 | EP application date | EAT | Apr 22, 2005 |
86 | WO application date | WAT | Apr 22, 2005 |
43 | Date of first publication | OT | Nov 3, 2005 |
| Date of publication of grant | PET | May 30, 2012 |
71/73 | Applicant/owner | INH | Celator Pharmaceuticals, Inc., Ewing, N.J., US |
72 | Inventor | IN | JOHNSTONE, Sharon, Vancouver, British Columbia V5V 2S1, CA; HARASYM, Troy, North Vancouver, British Columbia V7K 2K8, CA; MAYER, Lawrence, North Vancouver, British Columbia V7J 3M, CA |
74 | Representative | VTR | VEREENIGDE Octrooibureaux V.O., 80331 München, DE |
| Address for service | | VEREENIGDE Octrooibureaux V.O., 80331 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 565210 P Apr 22, 2004
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2018 000 134.1 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001744764 Searchable text:
EP000001744764 Original document:
EP000001744764B1 Searchable text:
EP000001744764B1 Original document: WO002005102359 Searchable text:
WO002005102359 |
43 | Date of first publication | EVT | Nov 3, 2005 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 24, 2025 (Show all update days)(Hide all update days)- Apr 24, 2025
- Status: changed
- IPC secondary class(es): changed
- Procedures: Administrative procedure, IP right lapsed through expiry of term of protection, 22.04.2025: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 30.05.2012: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 30.05.2012: deleted
- Mar 5, 2024; Mar 9, 2023; Mar 10, 2022; Jan 25, 2022; Mar 27, 2021; Apr 16, 2020; Aug 14, 2019; Apr 17, 2019; Jan 17, 2019; Dec 8, 2018; Oct 29, 2018; Apr 24, 2018; May 10, 2017; Apr 27, 2016; Apr 29, 2015; May 14, 2014; May 8, 2014; Aug 6, 2013; Jul 4, 2013; May 24, 2013; May 8, 2013; Jan 29, 2013; Aug 2, 2012; Jul 17, 2012; Jun 13, 2012; May 31, 2012; Dec 1, 2011
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|